drugset / Trial / NCT00005637

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

NCT00005637

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy following radiation therapy in treating patients who have malignant glioma.

Timeline

Start
1999-12
Primary completion
2003-06
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule Oral
Background carmustine Small molecule Intravenous